IRIDEX Corp (IRIX): Enterprise Value to EBITDA Ratio
Current price action helps assess the resilience of IRIDEX Corporation (IRIX), whose positions in ophthalmology are secured by unique patents and the complexity of physician retraining. Management aims to restore profitability by optimizing distribution channels, while the current EV/EBITDA ratio stands at 0.00. The company's growth relies on expansion into Asia and the popularization of gentle laser techniques for treating retinal pathologies.
Comprehensive metric breakdowns and analytics for iridex.com (IRIX)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
- financial results and valuation multiples details:
IRIX - Net Financial Result|Projected Future Earnings IRIDEX Corporation|IRIX - Price to Earnings Ratio|Forward P/E Multiple IRIDEX|IRIX - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization IRIDEX Corporation|IRIX - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months IRIDEX|IRIX - Earnings per share for the trailing year|Quarterly EPS earnings growth iridex.com|IRIX - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year IRIDEX Corporation
Analysis of all company metrics:IRIDEX Corp. IRIX
Steady demand for Cyclo G6 systems and consumables generates a cash flow that, within the EV/EBITDA formula, is compared against the total enterprise value of IRIDEX Corporation (IRIX), including net debt. By analyzing the EV/EBITDA ratio trend, an investor determines the premium paid for the asset: a critical increase in the metric relative to historical averages signals market overheating and the risk of a deep correction during a cycle shift.
Competitor analysis
Dexcom Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Penumbra Medical PEN|NOVT: Enterprise Value to EBITDA Ratio|haemonetics.com - Enterprise Value to Operating Income Before Depreciation Ratio|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (CONMED Corp.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Medical (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode Ltd.)|PMI (picardmedical.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Corp - EV/EBITDA Multiple|Company Value to EBITDA Tactile Systems Technology|SNWV: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation OM|ELMD (SmartVest) - EV/EBITDA Multiple|LENSAR Inc. (LNSR) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RCEL|Enterprise Value to EBITDA Ratio profoundmedical.com PROF|EV/EBITDA Multiple BDMD (Baird Medical)|EV/EBITDA Multiple EDAP TMS SA EDAP|APYX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ICCM: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG (pulmonx.com) - Enterprise Value to EBITDA Ratio|TELA Bio - Business Value to Operating Income Before Depreciation|CTSO (CytoSorbents Corp) - EV/EBITDA Multiple|Company Value to EBITDA sensushealthcare.com SRTS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zynex (ZYXI)|electrocore.com (ECOR) - Enterprise Value to EBITDA Multiple|Vicarious Surgical - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Inspira Technologies Oxy B.H.N. Ltd. IINN|SeaStar Medical Holding - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Intelligent Bio Solutions INBS|beyondair.net (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa Inc.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STRATA Skin Sciences Inc.|Enterprise Value to EBITDA Ratio GlucoTrack Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger Inc - Enterprise Value to Operating Income Before Depreciation Ratio|BSGM: EV/EBITDA Multiple|CUTR - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Know Labs|NARI: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple NVRO|Total Company Value to Operating Income Before Depreciation Ratio reshapelifesciences.com|EV/EBITDA Multiple SILK (Silk Road Medical, Inc)
